Chiron Names Robert Johnson Vice President of Pharmacology and Preclinical Affairs.EMERYVILLE, Calif.--(BW HealthWire)--Dec. 16, 1998--Chiron Corp. (Nasdaq:CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced today that Robert G. Johnson, Jr., M.D., Ph.D., 46, has been named vice president of pharmacology and preclinical affairs. In this position, Dr. Johnson will manage the development and evaluation of the company's preclinical products. Dr. Johnson will report to Lewis T. (Rusty) Williams, M.D., Ph.D., Chiron's chief scientific officer and president of Chiron Technologies. Dr. Johnson will concentrate his efforts in managing the evaluation of promising drug candidates identified within the company's secreted protein, gene therapy, functional genomics Noun 1. functional genomics - the branch of genomics that determines the biological function of the genes and their products genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) and small molecule programs designed to discover new compounds for the treatment of serious diseases in the areas of cardiovascular and infectious diseases and cancer. Prior to Chiron, Dr. Johnson served as director of pharmacology at the Merck Research Laboratories where he focused his efforts in the company's preclinical cardiovascular programs and served on several clinical project teams. In addition, he has extensive experience in biomedical research and development through his industry and academic appointments. "Our goal is to move the company's preclinical product candidates from research into clinical trials and establish priorities that enhance Chiron's success," said Dr. Williams. "We believe Robert's extensive experience in clinical and pharmaceutical development, his energy and incisiveness will add value to our team." Dr. Johnson is board certified board certified, adj the status of a dental specialist such as an orthodontist who has become a board diplomate by successfully completing the certification program of the recognized certification board in that area of practice. in internal medicine, endocrinology, and metabolism and has additional expertise in physiology, biochemistry, and biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle . He has held faculty positions at the Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. and the University of Pennsylvania School of Medicine The University of Pennsylvania's School of Medicine, presently located in the University City section of Philadelphia, Pennsylvania, was the United States's first school of medicine, founded at the College of Philadelphia, as the University was then called. , where he received his M.D. and Ph.D. in biochemistry and biophysics. He was also an associate investigator with the Howard Hughes Medical Institute Howard Hughes Medical Institute, (HHMI), nonprofit medical research organization founded in 1953 by Howard Hughes and largly funded from proceeds of the 1984–85 sale of Hughes Aircraft. Headquartered in Chevy Chase, Md. . Chiron Corp., headquartered in Emeryville, is a leading biotechnology company that participates in three global healthcare markets: therapeutics, blood testing and vaccines. Chiron also conducts research and development in the fields of recombinant technology, vaccines, gene therapy, small molecule discovery and genomics. For more information, visit the company's website at www.chiron.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion